Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.


Very few drugs, trial sites in search for Ebola cure

14 November 2014, 21:36

Geneva - Only a handful of drugs could potentially be tested on humans in the search for an Ebola cure, with even fewer sites equipped to host such trials, the World Health Organization said Friday.

The UN health agency briefing came a day after aid agency Doctors Without Borders said it would begin unprecedented trials of two antivirals, as well as the use of survivors' blood as therapy, on patients in west Africa.

There is no specific treatment regime for Ebola, which has killed more than 5,160 people, mainly in Guinea, Liberia and Sierra Leone, and the WHO has endorsed rushing possible treatments to trial in a bid to stem its murderous rampage.

But technical and scientific experts meeting in Geneva found numerous stumbling blocks to patient trials, the agency said.

Also read: Uganda free of Ebola-like Marburg virus

Of the more than 120 drugs put forward to the agency, only a very small number are both suitable and available for human trial, Martin Friede of the WHO's public health, innovation and intellectual property division, told reporters.

"We don't have actually a lot of drugs in our pipeline that look promising," he said.

The number of sites suited to carrying out tests on Ebola patients is also very limited, forcing WHO to further narrow its focus to a handful of drugs.

A key problem was that the drugs showing the most promise in animal trials are novel ones, like ZMapp, that are in very short supply and would be near impossible to scale up to a level that would allow proper testing.

"Conducting large clinical trials with these drugs is therefore going to be very difficult, if not impossible," he explained.

Isolated trials inconclusive

Friede also said the use of some of the drugs on 18 patients evacuated from west Africa, most of whom survived, was no help in in determining if they actually worked.

This was because they were given various combinations of drugs and had also received far higher quality of care than most patients in west Africa.

"It was impossible to draw any conclusion" on safety or efficacy from such isolated trials, he said.

This week's expert meeting pinpointed antiviral drug favipiravir, which works against influenza, and brincidofovir, used against adenovirus and cytomegalovirus as good candidates for trials.

Acting on the WHO experts' recommendation, MSF selected the two antivirals for its trials in west Africa.

Interferons could also be possible candidates, Friede said, adding that the experts had also discussed breast cancer drug toremifene, but found significant "safety concerns."

Where to conduct the tests was a major challenge, he said.

Because a good standard of overall care has a significant impact on Ebola survival rates, tests must be carried out across sites with consistently high care quality, as well as the infrastructure to support large clinical trials.

"We discovered in this meeting that there are no more than a handful of sites where such trials could actually be conducted under good conditions," Friede said.



Read News24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Read more from our Users

Nigeria @ 56: Words to my green f...

A leader’s job is not to dictate, but rather to be respected, admired and be a trustee, of the land we love, with so much potential, a land which should be freer than free. Its still a long way to fufilling our destiny! Read more...

Submitted by
Isaac Asabor263
Recession: An opportunity for Nig...

The recession should be seen as an opportunity for the country’s promotion as long as we all collectively conduct ourselves in a patriotic manner, writes Isaac Asabor.  Read more...

Submitted by
Black and White

We want to imitate the whites in everything because we are ignorant of our inherent originality and content. We spend all our Naira to acquire his inventions because we so oblivious of our natural endowments that we allow him have it for free. Read more...

Submitted by
Nate Nat
Adamawa State University Mubi: A ...

ADSU integrity forum has accused the Sunday Joshua Wugira, a lawyer, of adopting unorthodox tactics by abusing his privilege by attacking the integrity of ADSU Vice Chancellor Dr. Moses Zira Zaruwa, writes a News24 reader. Read more...

Submitted by
Abdulsalam Jubril
My Country Nigeria (Part One)

Poetry by Abdulsalam Jubril.

Submitted by
Abdulsalam Jubril
Recession, dearth in leadership a...

Every leader has the opportunity to become great and making himself immortal in the lives and hearts of people for generations to come. Will Mr. President seize this opportunity?, questions Abdulsalam Jubril. Read more...